abstract |
Cancer therapies and anticancer compounds are described. In particular, inhibitors of ACK1 tyrosine kinase and their use in the treatment of cancer are disclosed. Also disclosed are methods of screening novel ACK1 tyrosine kinase inhibitors. In particular examples, compounds having Formulas I-IV are disclosed. |